Reading AVNT? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track AVNT free→Reading AVNT? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track AVNT free→NYSEMaterialsSpecialty ChemicalsSnapshot 2026-06-15
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
Recent financial performance is strong, while earnings quality is neutral and management's recent track record has been steady. Risk is moderate, and the sector backdrop presents a headwind. Peer multiples imply a price about 23% above where it trades (it looks cheap on this basis); the read is fair. Key factors to watch include any potential guidance cuts and the performance of sector bellwethers like LIN, SHW, and ECL, as these could significantly impact AVNT. This read is provisional.
Daily closes. Earnings/event dots are placed inline.
A consensus fair price across 8 valuation methods, at three horizons. Current price $37.53. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
No-growth: today's peer multiple on trailing earnings. The headline read.
Embeds projected growth. Leans optimistic by design. Upside context.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $38 AVNT trades at 16× p/e, below its 21× p/e peer median. Our $48 fair value sits above the price; high confidence. Analysts: $43–$52. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
The price implies about 22% below a flat-multiple fair value, below our forecast of about -2%. This describes what's priced in, not a forecast of the move.
No fragility gates fired. Regime (Crisis) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 1 of the last 3 quarter-over-quarter moves. Historically, Materials names rated strong grew net income 63% of the time over the next year (vs 54% for the rest of the cohort, n=1093).
Over the trailing year it converted 2.02x of net income into operating cash flow. Historically, Materials names rated neutral grew net income 52% of the time over the next year (vs 55% for the rest of the cohort, n=1297).
Most sensitive to the broad stock market.
Not enough signal to read sensitivity to the US dollar, real (inflation-adjusted) rates, long-term interest rates, Fed net liquidity.
The next print and the backdrop around it (sector regime and the AI cycle). Context for the path, not a forecast of returns.
EPS estimate $0.89 → $0.89 (-0.0% / 30d). 3 raised, 2 cut, 9 covering analysts.
0 upgrades, 0 downgrades / 30d. 75% of analysts rate Buy.
2 PT revisions / 30d. Avg target 29.6% above current price.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
Met or beat guidance 100% of the last 1 guided quarters · 0.0% avg surprise
What a normal day, a bad day, and the worst of the last year would mean for a $10,000 position.
On a typical day, $10k can swing ±$153.
How much price usually moves either way.
On a bad day, this stock has moved -$310.
A rough but not unusual down day (about the 95th percentile).
In the worst 12 months, $10k could have lost $2,688.
Deepest peak-to-trough drop in the last year.
Past results, not a forecast. Not investment advice.
The most important moves since the prior daily snapshot.
No material changes since the prior snapshot.
as of 2026-06-15
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Why it matters: Meeting or exceeding this EPS target shows strong earnings growth and execution.
Confirms:Q2 adjusted EPS reported at $0.89 or higher.
Disproves:Q2 adjusted EPS reported below $0.89.
Recent news graded against this company's own objectives — whether it reinforces or challenges the thesis, and how confirmed it is.
No graded news catalysts for AVNT yet.
Conditional scenarios: if X happens, the view would shift in this direction. These are not predictions.
Recent SEC 8-K filings ranked by likely impact, confidence, and recency.
Results of Operations and Financial Condition. On May 7, 2026, the Registrant issued a press release, furnished herewith as Exhibit 99.1, announcing earnings for the first quarter of 2026. The press release shall not be deemed to be “filed” under the Securities Exchange Act of 1934.
Whether the overall read has been drifting up or down lately, and how it's changed since last week.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Long-thesis check; widest uncertainty.
$43.00 – $52.00 (median $44.00) · 4 analysts · as of 2026-06-08
Looks cheaper than most peers in the same business.
Around its own typical valuation.
Trailing four: 2025-Q1, 2025-Q2, 2025-Q3, 2026-Q1
A side-by-side read on sector standing, valuation, and risk versus Specialty Chemicals.
| Stock | Sector standing | Valuation | Risk |
|---|---|---|---|
AVNT Avient | Typical Show detailsSector percentile: 63 of 100 | fair | moderate |
SHW Sherwin-Williams | Typical Show detailsSector percentile: 67 of 100 | full | moderate |
ECL Ecolab | Above typical Show detailsSector percentile: 83 of 100 | expensive | moderate |
PPG PPG Industries | Above typical Show detailsSector percentile: 90 of 100 | fair | moderate |
LYB LyondellBasell | Typical Show detailsSector percentile: 55 of 100 | — | moderate |
1 material management or governance event in the past 24 months, led by executive changes. Historically, Materials names rated stable grew net income 45% of the time over the next year (vs 58% for the rest of the cohort, n=210).
Not investment advice. As of 2026-06-15.
via XLB
Tailwind = sector leading the S&P 500; headwind = trailing. Both can be constructive. Historically, headwind regimes have averaged stronger forward returns than tailwind.
Context label only: describes the market state (e.g. real bear vs narrative panic, healthy uptrend vs late-stage froth). It is not a per-ticker buy/sell signal and does not predict factor performance.
Not investment advice. As of 2026-06-15.
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
Avient aims to maintain its full year adjusted EPS guidance of $2.93 to $3.17.
Focus on productivity improvement and disciplined cost control to enhance margins.
Proactively work to secure raw material supply amidst macro-economic uncertainty.
Focus on increasing operating income through cost management and efficiency improvements.
Aim to enhance gross profit through strategic initiatives and operational efficiencies.
Why it matters: A new CFO could change financial strategies and outlook.
Confirms one read:The new CFO gives a positive outlook and confirms current guidance.
Confirms the other:New CFO issues a cautious outlook or lowers guidance.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Agreements of Certain Officers. On April 22, 2026, Avient Corporation (the “Company”) was notified by Jamie A. Beggs that she intends to resign from her position as Senior Vice President and Chief Financial Officer and as an employee, effective June 1, 2026, to pursue other professional opportunities. Ms. Beggs’ resignation was not the result of any disagreement with the Company on…
Results of Operations and Financial Condition. On February 12, 2026, the Registrant issued a press release, furnished herewith as Exhibit 99.1, announcing earnings for the fourth quarter of 2025. The press release shall not be deemed to be “filed” under the Securities Exchange Act of 1934.